Technological Paradigms and Trajectories as Determinants of the R&D Corporate Change in Drug Discovery Industry
Coccia, M. (2015) ‘Technological paradigms and trajectories as determinants of the R&D corporate change in drug discovery industry’, Int. J. Knowledge and Learning, Vol. 10, No. 1, pp.29–43.
15 Pages Posted: 4 Aug 2015
Date Written: August 3, 2015
Abstract
The present inductive study shows two main effects of new technological paradigms in medicine driven by convergent genomics, genetics and proteomics (e.g., targeted therapies): 1) division of scientific/technological labour by strategic alliances among firms to reinforce the integrative capabilities in different biomedical research fields in order to support drug discovery process; 2) cumulative and collective learning by network R&D organisations to integrate in-house R&D and external sources of innovation in order to accelerate the discovery of path-breaking drugs for personalised healthcare. Relationships between observed facts are analysed to establish some general implications concerning the impact of technological paradigms on R&D corporate change for supporting the modern discovery process.
Keywords: technological paradigm; labour division; learning process
JEL Classification: O31, O32
Suggested Citation: Suggested Citation